1 week Ago By ABMN Staff
California Public Employees Retirement System decreased its holdings in Bruker Co. ( NASDAQ:BRKR – Free Report ) by 9.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission.
The fund owned 153,581 shares of the medical research company’s stock after selling 16,593 shares during the quarter. California Public Employees Retirement System’s holdings in Bruker were worth $9,003,000 at the end of the most recent reporting period. A number of other institutional investors and hedge funds have also bought and sold shares of the stock.
Norges Bank acquired a new position in Bruker during the 4th quarter worth about $63,378,000. Vaughan Nelson Investment Management L.P.
lifted its stake in shares of Bruker by 140.3% in the fourth quarter. Vaughan Nelson Investment Management L.
P. now owns 1,141,762 shares of the medical research company’s stock worth $66,930,000 after acquiring an additional 666,617 shares during the period. State Street Corp boosted its holdings in Bruker by 9.
6% in the third quarter. State Street Corp now owns 3,627,300 shares of the medical research company’s stock valued at $250,501,000 after acquiring an additional 318,808 shares during the last quarter. JPMorgan Chase & Co.
increased its position in Bruker by 139.3% during the 4th quarter. JPMorgan Chase & Co.
now owns 526,166 shares of the medical research company’s stock valued at $30,844,000 after purchasing an additional 306,282 shares during the period. Finally, Brown Brothers Harriman & Co. raised its holdings in Bruker by 37.
8% during the 4th quarter. Brown Brothers Harriman & Co. now owns 829,763 shares of the medical research company’s stock worth $48,641,000 after purchasing an additional 227,619 shares during the last quarter.
79.52% of the stock is currently owned by institutional investors and hedge funds. Bruker Price Performance Shares of NASDAQ:BRKR opened at $36.
46 on Monday. Bruker Co. has a twelve month low of $34.
10 and a twelve month high of $91.34. The stock’s 50 day moving average is $48.
64 and its 200-day moving average is $56.00. The company has a quick ratio of 0.
77, a current ratio of 1.60 and a debt-to-equity ratio of 1.15.
The firm has a market capitalization of $5.53 billion, a price-to-earnings ratio of 47.97, a PEG ratio of 2.
16 and a beta of 1.18. Bruker Announces Dividend The business also recently disclosed a quarterly dividend, which was paid on Friday, March 28th.
Shareholders of record on Monday, March 17th were paid a dividend of $0.05 per share. This represents a $0.
20 annualized dividend and a yield of 0.55%. The ex-dividend date was Monday, March 17th.
Bruker’s dividend payout ratio (DPR) is presently 26.32%. Wall Street Analysts Forecast Growth A number of equities research analysts have recently commented on the stock.
Stifel Nicolaus reduced their price objective on shares of Bruker from $70.00 to $57.00 and set a “hold” rating on the stock in a research note on Friday, February 14th.
UBS Group initiated coverage on shares of Bruker in a research report on Tuesday, December 10th. They set a “neutral” rating and a $66.00 price target on the stock.
Barclays lowered their price objective on Bruker from $69.00 to $65.00 and set an “overweight” rating for the company in a research report on Monday, February 10th.
Guggenheim reaffirmed a “buy” rating on shares of Bruker in a research note on Monday, February 24th. Finally, Bank of America boosted their price target on Bruker from $78.00 to $80.
00 and gave the company a “buy” rating in a research note on Friday, December 13th. Six research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $70.
50. Check Out Our Latest Stock Report on BRKR About Bruker ( Free Report ) Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
Further Reading Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Co. ( NASDAQ:BRKR – Free Report ).
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter ..
